Skip to main content
. 2025 Jul 14;17(7):e87878. doi: 10.7759/cureus.87878

Figure 2. Patient case photographs courtesy of Dr. Frank Lin.

Figure 2

Patient shown before (A) and 12 months after (B) treatment. A 42-year-old East Asian female who was very thin, had midface hollowing and significant A-frame deformity and infraorbital hollowing, sought treatment for a tired appearance around the midface and periorbital area. Over two sessions, she received incobotulinumtoxin A (Merz North America, Raleigh, NC, USA) for the masseter and diluted CaHA-CMC for temple contouring and submalar depressions, as well as a CaHA-CMC diluted 1:2 as a mid-cheek pan-facial wash. Undiluted or minimally diluted CaHA-CMC was also placed in the chin and deep pyriform fossa, while hyaluronic acid (Merz North America, Raleigh, NC, USA) was applied to the A-frame and tear trough area. Written informed consent to include this image in an open-access article was obtained from the patient.

CaHA-CMC: calcium hydroxyapatite-carboxymethylcellulose